3Mixtatin Versus Modified 3Mix-MP in Lesion Sterilization and Tissue Repair for Treatment of Necrotic Primary Molars (LSTR)
Necrotic Primary Molars
About this trial
This is an interventional treatment trial for Necrotic Primary Molars focused on measuring 3MIX-MP, 3Mixtatin, LSTR
Eligibility Criteria
Inclusion Criteria: Pediatric patients aged 4-7 years. Positive parental informed consent. Restorable necrotic mandibular second primary molars with peri-radicular/furcal involvement and/or pathologic root resorption (external or internal). Presence of chronic apical abscess or sinus tract or furcation radiolucency. (Thakur et al., 2021) Exclusion Criteria: Medically compromised children. Children with known allergy to any of the components being utilized. Molars near exfoliation. Molars with severely resorbed roots more than two thirds indicated for extraction Molars with insufficient coronal structure disabling proper coronal seal. Presence of periapical or interradicular radiolucent area which could compromise the permanent tooth bud. (Shetty et al., 2020)
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Experimental
Active Comparator
(Group I Experimental Group):Simvastatin mixed with modified triple antibiotic (3Mixtatin)
Group II Control group Modified triple antibiotic mix in propylene glycol (3Mix)
Patients will then be allocated into either one of the groups alternatively after access cavity preparation depending on the mix to be used as follows: for this group: 2mg of pure Simvastatin powder will be added to the 1:1:1 3Mix powder and will be stored together in an air tight porcelain container to avoid the exposure to moisture and light. Upon clinical application the 3Mixtatin powder will be mixed with normal saline to form a paste and is then applied in the same manner as the Modified 3Mix-MP paste.
Removal of enteric coating/capsule of the three antibiotic tablets using a surgical blade. 500 mg Metronidazole tab 500 mg Ciprofloxacin tab 200 mg Cefixime caps Pulverization of each of the drug, will be done using a pestle & mortar, stored in an air tight porcelain container to avoid the exposure to moisture & light. Pulverized powders will be stored at a temperature of 16°C.Powder should be allowed to be cooled to the room temperature before initiating the preparation of 3Mix-MP paste. Powders will be mixed in the proportion of: 1:1:1 by volume (Hoshino et al., 1988). Vehicle that will be used is Systane eye drops (Kharadly et al., 2022) it contains the two main components propylene Glycol (Macrogol) & polyethylene glycol. The prepared antibiotic powder is mixed with the prepared vehicle in the ratio of 7:1 by volume. The two steps above are done after access cavity preparation to obtain a fresh mix.